Research graph
References from Quantitative characterization of L-citrulline as a precursor of L-arginine in rats: pharmacokinetic basis for nitric oxide-mediated effects. Local targets link to admitted publications; unresolved targets remain external evidence.
Supplemental citrulline is more efficient than arginine in increasing systemic arginine availability in mice
10.3945/jn.116.240382 · 2017 · External reference
l-Citrulline supplementation: impact on cardiometabolic health
10.3390/nu10070921 · 2018 · External reference
Role of nitric oxide in insulin secretion and glucose metabolism
10.1016/j.tem.2019.10.001 · 2020 · External reference
Asymmetric dimethylarginine, an endogenous inhibitor of nitric oxide synthase, explains the “L-arginine paradox” and acts as a novel cardiovascular risk factor
10.1093/jn/134.10.2842s · 2004 · External reference
L-Arginine supplementation in type II diabetic rats preserves renal function and improves insulin sensitivity by altering the nitric oxide pathway
10.1155/2014/171546 · 2014 · External reference
L-Arginine in diabetes: clinical and preclinical evidence
10.1186/s12933-023-01827-2 · 2023 · External reference
Supplementation with nitric oxide precursors for strength performance: a review of the current literature
10.3390/nu15030660 · 2023 · External reference
Utilization of area under the curve to elucidate the disposition of an extensively biotransformed drug
10.1007/bf01062347 · 1973 · External reference
Nitric oxide signaling in health and disease
10.1016/j.cell.2022.06.010 · 2022 · External reference
Plasma arginine and ornithine are the main citrulline precursors in mice infused with arginine-free diets
10.3945/jn.110.125377 · 2010 · External reference
A rapid, simple spectrophotometric method for simultaneous detection of nitrate and nitrite
10.1006/niox.2000.0319 · 2001 · External reference
Dose-ranging effects of citrulline administration on plasma amino acids and hormonal patterns in healthy subjects: the citrudose pharmacokinetic study
10.1017/s0007114507841110 · 2008 · External reference
Citrulline increases arginine pools and restores nitrogen balance after massive intestinal resection
10.1136/gut.2004.042317 · 2004 · External reference
Citrulline in health and disease. Review on human studies
10.1016/j.clnu.2017.10.009 · 2018 · External reference
Dietary arginine and citrulline supplements for cardiovascular health and athletic performance: a narrative review
10.3390/nu15051268 · 2023 · External reference
Therapeutic potential of citrulline as an arginine supplement: a clinical pharmacology review
10.1007/s40272-020-00384-5 · 2020 · External reference
Unresolved reference
2011 · External reference
Pharmacokinetic and pharmacodynamic properties of oral L-citrulline and L-arginine: impact on nitric oxide metabolism
10.1111/j.1365-2125.2007.02990.x · 2008 · External reference
Population pharmacokinetics of a novel histone deacetylase inhibitor, cyclo(2S)-2-amino-8-[(aminocarbonyl)hydrazono] decanoyl-1-L-tryptophyl-L-isoleucyl-(2R)-2-piperidinecarbonyl (SD-2007), and its metabolic conversion to apicidin after intravenous injection and oral administration in rats
10.1159/000328027 · External reference
Simultaneous bioanalysis of l-arginine, l-citrulline, and dimethylarginines by LC–MS/MS
10.1016/j.jchromb.2011.01.006 · External reference
Intracellular L-arginine concentration does not determine NO production in endothelial cells: implications on the L-arginine paradox
10.1016/j.bbrc.2011.09.112 · External reference
Estimation of nitric oxide synthase activity via liquid chromatography/tandem mass spectrometric assay determination of 15N3 -citrulline in biological samples
10.1002/rcm.7124 · 2015 · External reference
Cellular interactions between L-arginine and asymmetric dimethylarginine: transport and metabolism
10.1371/journal.pone.0178710 · 2017 · External reference
Simultaneous analysis of acetylcarnitine, proline, hydroxyproline, citrulline, and arginine as potential plasma biomarkers to evaluate NSAIDs-induced gastric injury by liquid chromatography-tandem mass spectrometry
10.1016/j.jpba.2018.11.051 · 2019 · External reference
Pharmacokinetics of intravenous and oral L-arginine in normal volunteers
10.1046/j.1365-2125.1999.00883.x · 1999 · External reference
Endogenous nitric oxide synthase inhibitors are responsible for the L-arginine paradox
10.1016/s0014-5793(00)01686-0 · 2000 · External reference
Unresolved reference
2018 · External reference
Long term exposure to L-arginine accelerates endothelial cell senescence through arginase-II and S6K1 signaling
10.18632/aging.100663 · 2014 · External reference
